- conflicts or gaps
- [{"founded_year_discrepancy": {"value": "Company self-reports 2008 founding (bootstrap era); YC and LinkedIn list 2015 (YC batch year)", "source_urls": ["https://cofactorgenomics.com/lessons-learned-from-cofactors-y-combinator-experience-7-months-later/", "https://www.ycombinator.com/companies/cofactor-genomics", "https://www.linkedin.com/company/cofactorgenomics"]}, "headquarters_discrepancy": {"value": "Primary HQ consistently St. Louis in press/YC; CB Insights and Gaebler list San Francisco (300 Brannan St) as headquarters—likely legacy of Narus acquisition office", "source_urls": ["https://www.cbinsights.com/company/cofactor-genomics", "https://cofactorgenomics.com/narus/", "https://www.businesswire.com/news/home/20251215728487/en/Cofactor-Genomics-Announces-Strategic-Investment-by-Labcorp-and-Ascension-Ventures-to-Fuel-Expansion-of-Its-OncoPrism-Immunotherapy-Diagnostic-Across-U-S-Cancer-Care-Networks"]}, "headcount_discrepancy": {"value": "Employee counts vary: YC 13, LinkedIn 9, Tracxn/LeadIQ ~11; no official disclosure", "source_urls": ["https://www.ycombinator.com/companies/cofactor-genomics", "https://www.linkedin.com/company/cofactorgenomics", "https://tracxn.com/d/companies/cofactorgenomics/__ev5b89qI1VlBL_dt3LsiBPPssZZKJ3uRwSVPy-UAWQs"]}, "total_funding_discrepancy": {"value": "Third-party totals range $25M–$29.2M; December 2025 Labcorp/Ascension round amount not publicly disclosed", "source_urls": ["https://www.cbinsights.com/company/cofactor-genomics", "https://tracxn.com/d/companies/cofactorgenomics/__ev5b89qI1VlBL_dt3LsiBPPssZZKJ3uRwSVPy-UAWQs/funding-and-investors", "https://www.linkedin.com/company/cofactorgenomics", "https://www.businesswire.com/news/home/20251215728487/en/Cofactor-Genomics-Announces-Strategic-Investment-by-Labcorp-and-Ascension-Ventures-to-Fuel-Expansion-of-Its-OncoPrism-Immunotherapy-Diagnostic-Across-U-S-Cancer-Care-Networks"]}, "founder_status_stale_data": {"value": "Dave Messina listed as active COO on some LinkedIn snapshots but YC lists him as Former Founder; current leadership is Chris Parker (CEO), Jarret Glasscock (President/CTO), Jon Armstrong (CSO)", "source_urls": ["https://www.ycombinator.com/companies/cofactor-genomics", "https://www.linkedin.com/company/cofactorgenomics", "https://cofactorgenomics.com/our-story/"]}, "predapt_partner_count": {"value": "Company website cites 24+ healthcare systems in PREDAPT; press releases cite 38 healthcare systems partnered/supported", "source_urls": ["https://cofactorgenomics.com", "https://www.businesswire.com/news/home/20241018274851/en/Cofactor-Genomics-receives-Medicare-coverage-for-OncoPrism-a-machine-learning-based-RNA-oncology-test-predicting-immunotherapy-response"]}, "undisclosed_items": {"value": "Dec 2025 investment size; full cap table; valuation; revenue (LinkedIn $15M estimate unverified); identity of nine pharma contracts from 2015", "source_urls": ["https://www.businesswire.com/news/home/20251215728487/en/Cofactor-Genomics-Announces-Strategic-Investment-by-Labcorp-and-Ascension-Ventures-to-Fuel-Expansion-of-Its-OncoPrism-Immunotherapy-Diagnostic-Across-U-S-Cancer-Care-Networks", "https://techcrunch.com/2015/07/31/cofactor-genomics/", "https://www.linkedin.com/company/cofactorgenomics"]}}]
- source urls
- ["https://cofactorgenomics.com", "https://cofactorgenomics.com/lessons-learned-from-cofactors-y-combinator-experience-7-months-later/", "https://cofactorgenomics.com/narus/", "https://cofactorgenomics.com/oncoprism/", "https://cofactorgenomics.com/our-story/", "https://cofactorgenomics.com/team/randolph-skinner/", "https://leadiq.com/c/cofactor-genomics/5a1d8a8f24000024006441de/employee-directory", "https://missouripartnership.com/st-louis-research-firm-gains-attention-from-silicon-valley-investors/", "https://techcrunch.com/2015/07/31/cofactor-genomics/", "https://tracxn.com/d/companies/cofactorgenomics/__ev5b89qI1VlBL_dt3LsiBPPssZZKJ3uRwSVPy-UAWQs", "https://tracxn.com/d/companies/cofactorgenomics/__ev5b89qI1VlBL_dt3LsiBPPssZZKJ3uRwSVPy-UAWQs/funding-and-investors", "https://www.businesswire.com/news/home/20241018274851/en/Cofactor-Genomics-receives-Medicare-coverage-for-OncoPrism-a-machine-learning-based-RNA-oncology-test-predicting-immunotherapy-response", "https://www.businesswire.com/news/home/20250108539488/en/Cofactor-Genomics-Inc.-Announces-CEO-Transition-in-Preparation-for-Accelerated-Commercial-Growth-and-Increased-Patient-Access-for-OncoPrism-its-Medicare-Approved-Immunotherapy-Test", "https://www.businesswire.com/news/home/20250305887608/en/Cofactor-Genomics-Announces-the-Expansion-of-OncoPrism-into-Colorectal-Breast-Bladder-and-Kidney-Cancer", "https://www.businesswire.com/news/home/20251215728487/en/Cofactor-Genomics-Announces-Strategic-Investment-by-Labcorp-and-Ascension-Ventures-to-Fuel-Expansion-of-Its-OncoPrism-Immunotherapy-Diagnostic-Across-U-S-Cancer-Care-Networks", "https://www.businesswire.com/news/home/20251217132520/en/Cofactor-Genomics-Advances-Predictive-Cancer-Diagnostics-With-Landmark-OncoPrism-NSCLC-Study", "https://www.cbinsights.com/company/cofactor-genomics", "https://www.gaebler.com/VC-Funding-89B12EF1-E47C-4EC4-87ED-C2E68A925874-Cofactor-Genomics-08-19-2015", "https://www.genomeweb.com/sequencing/cofactor-genomics-raises-18m-series-round", "https://www.linkedin.com/company/cofactorgenomics", "https://www.seedtable.com/startups/Cofactor_Genomics-WDAGKK", "https://www.ycombinator.com/blog/cofactor-genomics-yc-s15-is-studying-rna-testing-to-diagnose-disease-earlier", "https://www.ycombinator.com/companies/cofactor-genomics"]